Reprogrammed marrow adipocytes contribute to myeloma-induced bone disease

A robust and high-throughput Cre reporting and characterization system for the whole mouse brain

Madisen, L., Zwingman, T. A., Sunkin, S. M., Oh, S. W., Zariwala, H. A., Gu, H., Ng, L. L., Palmiter, R. D., Hawrylycz, M. J., Jones, A. R., et al. (2010) · Nature Neuroscience · doi:10.1038/nn.2467 · Cited by 6,907

Cold-Activated Brown Adipose Tissue in Healthy Men

van Marken Lichtenbelt, W. D., Vanhommerig, J. W., Smulders, N. M., Drossaerts, J. M. A. F. L., Kemerink, G. J., Bouvy, N. D., Schrauwen, P., & Teule, G. J. J. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808718 · Cited by 3,452

Multiple Myeloma

Palumbo, A. P., & Anderson, K. C. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1011442 · Cited by 2,382

Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth

Nieman, K. M., Kenny, H. A., Penicka, C. V., Ladanyi, A., Buell-Gutbrod, R., Zillhardt, M. R., Romero, I. L., Carey, M. S., Mills, G. B., Hotamisligil, G. S., et al. (2011) · Nature Medicine · doi:10.1038/nm.2492 · Cited by 2,279

Histone methylation: a dynamic mark in health, disease and inheritance

Greer, E. L., & Shi, Y. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3173 · Cited by 2,241

Multiple myeloma

Raje, N. S., & Anderson, K. C. (2000) · Current Treatment Options in Oncology · doi:10.1007/s11864-000-0017-x · Cited by 2,164

Fat and Beyond: The Diverse Biology of PPARγ

Tontonoz, P., & Spiegelman, B. M. (2008) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.77.061307.091829 · Cited by 2,085

The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene

Yoshida, H., Hayashi, S.-I., Kunisada, T., Ogawa, M., Nishikawa, S., Okamura, H., Sudo, T., Shultz, L. D., & Nishikawa, S.-I. (1990) · Nature · doi:10.1038/345442a0 · Cited by 1,789

The Role of the Wnt-Signaling Antagonist DKK1 in the Development of Osteolytic Lesions in Multiple Myeloma

Tian, E., Zhan, F., Walker, R. C., Rasmussen, E., Ma, Y., Barlogie, B., & Shaughnessy, J. D. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030847 · Cited by 1,505

Genome Regulation by Polycomb and Trithorax Proteins

Schuettengruber, B., Chourrout, D., Vervoort, M., Leblanc, B., & Cavalli, G. (2007) · Cell · doi:10.1016/j.cell.2007.02.009 · Cited by 1,418

Invasion and metastasis in cancer: molecular insights and therapeutic targets

Li, Y., Liu, F., Cai, Q., Deng, L., Ouyang, Q., Zhang, X. H.-F., & Zheng, J. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02148-4 · Cited by 314

Monocyte-derived macrophages promote breast cancer bone metastasis outgrowth

Ma, R., Zhang, H., Li, X., Zhang, C., Selli, Ç., Tagliavini, G., Lam, A. D., Prost, S., Sims, A. H., Hu, H., et al. (2020) · The Journal of Experimental Medicine · doi:10.1084/jem.20191820 · Cited by 166

Induction of m6A methylation in adipocyte exosomal LncRNAs mediates myeloma drug resistance

Wang, Z., He, J., Bach, D., Huang, Y.-H., Li, Z., Liu, H., Lin, P., & Yang, J. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-02209-w · Cited by 124

Multiple myeloma cells induce lipolysis in adipocytes and uptake fatty acids through fatty acid transporter proteins

Panaroni, C., Fulzele, K. S., Mori, T., Siu, K. T., Onyewadume, C., Maebius, A., & Raje, N. S. (2021) · Blood · doi:10.1182/blood.2021013832 · Cited by 118

Acetyl-CoA Synthetase 2: A Critical Linkage in Obesity-Induced Tumorigenesis in Myeloma

Li, Z., Liu, H., He, J., Wang, Z., Yin, Z., You, G., Wang, Z., Davis, R. E., Lin, P., Bergsagel, P. L., et al. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2020.12.011 · Cited by 110

Drilling for Oil: Tumor-Surrounding Adipocytes Fueling Cancer

Attané, C., & Muller, C. (2020) · Trends in Cancer · doi:10.1016/j.trecan.2020.03.001 · Cited by 97

Myeloma-Modified Adipocytes Exhibit Metabolic Dysfunction and a Senescence-Associated Secretory Phenotype

Fairfield, H. E., Dudakovic, A., Khatib, C. M., Farrell, M. L., Costa, S., Falank, C. R., Hinge, M., Murphy, C. S., DeMambro, V., Pettitt, J. A., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-20-1088 · Cited by 91

CHEK1 and circCHEK1_246aa evoke chromosomal instability and induce bone lesion formation in multiple myeloma

Gu, C., Wang, W., Tang, X., Xu, T., Zhang, Y., Guo, M., Wei, R., Wang, Y., Jurczyszyn, A. J., Janz, S., et al. (2021) · Molecular Cancer · doi:10.1186/s12943-021-01380-0 · Cited by 70

Myeloma Cells Down-Regulate Adiponectin in Bone Marrow Adipocytes Via TNF-Alpha

Morris, E. V., Suchacki, K. J., Hocking, J., Cartwright, R., Sowman, A., Gámez, B., Lea, R., Drake, M. T., Cawthorn, W. P., & Edwards, C. M. (2019) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3951 · Cited by 68

Bone Marrow Adipose Tissue

Busilacchi, E. M., Morsia, E., & Poloni, A. (2024) · Cells · doi:10.3390/cells13090724 · Cited by 60

Bone Marrow Adipocytes: A Critical Player in the Bone Marrow Microenvironment

Wang, L., Zhang, H., Wang, S., Chen, X., & Su, J. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.770705 · Cited by 55

Melatonin enhances osteoblastogenesis of senescent bone marrow stromal cells through NSD2‐mediated chromatin remodelling

Xie, Y., Han, N., Li, F., Wang, L., Liu, G., Hu, M., Wang, S., Wei, X., Guo, J. R., Jiang, H., et al. (2022) · Clinical and Translational Medicine · doi:10.1002/ctm2.746 · Cited by 51

Myeloma cells shift osteoblastogenesis to adipogenesis by inhibiting the ubiquitin ligase MURF1 in mesenchymal stem cells

Liu, Z., Liu, H., He, J., Lin, P., Tong, Q., & Yang, J. (2020) · Science Signaling · doi:10.1126/scisignal.aay8203 · Cited by 49

Mechanism of regulating macrophages/osteoclasts in attenuating wear particle-induced aseptic osteolysis

Yin, Z., Gong, G., Liu, X., & Yin, J. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1274679 · Cited by 45

Multiple Myeloma Cells Alter Adipogenesis, Increase Senescence-Related and Inflammatory Gene Transcript Expression, and Alter Metabolism in Preadipocytes

Fairfield, H., Costa, S., Falank, C., Farrell, M., Murphy, C. S., D’Amico, A., Driscoll, H., & Reagan, M. R. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2020.584683 · Cited by 42

m6A reader hnRNPA2B1 drives multiple myeloma osteolytic bone disease

Liu, R., Zhong, Y., Chen, R., Chu, C., Liu, G., Zhou, Y., Huang, Y., Fang, Z., & Liu, H. (2022) · Theranostics · doi:10.7150/thno.76852 · Cited by 35

Obesity and myeloma: Clinical and mechanistic contributions to disease progression

Marques-Mourlet, C., Iorio, R. D., Fairfield, H. E., & Reagan, M. R. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1118691 · Cited by 38

A Review of the Action of Magnesium on Several Processes Involved in the Modulation of Hematopoiesis

Lima, F. D. S., & Fock, R. A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197084 · Cited by 34

Bone Marrow Adipocytes: A Link between Obesity and Bone Cancer

Reagan, M. R., Fairfield, H. E., & Rosen, C. J. (2021) · Cancers · doi:10.3390/cancers13030364 · Cited by 28

Mesenchymal stromal cells in bone marrow niche of patients with multiple myeloma: a double-edged sword

Kamrani, S., Naseramini, R., Khani, P., Razavi, Z. S., Afkhami, H., Atashzar, M. R., Nasri, F., Alavimanesh, S., Saeidi, F., & Ronaghi, H. (2025) · Cancer Cell International · doi:10.1186/s12935-025-03741-x · Cited by 27

Lipid metabolic vulnerabilities of multiple myeloma

Torcasio, R., Cantafio, M. E. G., Ikeda, R. K., Ganino, L., Viglietto, G., & Amodio, N. (2023) · Clinical and Experimental Medicine · doi:10.1007/s10238-023-01174-2 · Cited by 28

Osteocyte CIITA aggravates osteolytic bone lesions in myeloma

Liu, H., He, J., Bagheri‐Yarmand, R., Li, Z., Liu, R., Wang, Z., Bach, D., Huang, Y.-H., Lin, P., Guise, T. A., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-31356-7 · Cited by 27

Multiple myeloma metabolism – a treasure trove of therapeutic targets?

Román-Trufero, M., Auner, H. W., & Edwards, C. M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.897862 · Cited by 26

Shared Genes of PPARG and NOS2 in Alzheimer’s Disease and Ulcerative Colitis Drive Macrophages and Microglia Polarization: Evidence from Bioinformatics Analysis and Following Validation

Dong, L., Shen, Y., Li, H., Zhang, R., Yu, S., & Wu, Q. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065651 · Cited by 25

Clinical implications of differential functional capacity between tissue‐specific human mesenchymal stromal/stem cells

Yen, B. L., Liu, K., Sytwu, H., & Yen, M. (2022) · FEBS Journal · doi:10.1111/febs.16438 · Cited by 23

It is worth the weight: obesity and the transition from monoclonal gammopathy of undetermined significance to multiple myeloma

Choa, R., Panaroni, C., Bhatia, R., & Raje, N. S. (2023) · Blood Advances · doi:10.1182/bloodadvances.2023010822 · Cited by 23

Therapeutic targets in myeloma bone disease

Marino, S., Petrusca, D. N., & Roodman, G. D. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14889 · Cited by 22

Bone marrow stromal cells dictate lanosterol biosynthesis and ferroptosis of multiple myeloma

Jiang, H., Wang, L., Zhang, Q., Wang, S., Jia, L., Cheng, H., Wang, J., Li, X., Xie, Y., Wang, Y., et al. (2024) · Oncogene · doi:10.1038/s41388-024-03020-5 · Cited by 23

Cross Talk Between Macrophages and Cancer Cells in the Bone Metastatic Environment

Batoon, L., & McCauley, L. K. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.763846 · Cited by 22

Metabolic crosstalk between stromal and malignant cells in the bone marrow niche

Tirado, H. A., Balasundaram, N., Laaouimir, L., Erdem, A., & van Gastel, N. (2023) · Bone Reports · doi:10.1016/j.bonr.2023.101669 · Cited by 25

Distinct Metabolism of Bone Marrow Adipocytes and their Role in Bone Metastasis

Li, Y., Cao, S., Gaculenko, A., Zhan, Y., Bözec, A., & Chen, X. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.902033 · Cited by 22

comBO: A combined human bone and lympho-myeloid bone marrow organoid for preclinical modeling of hematopoietic disorders

Shen, Y., Benlabiod, C., Watson, E., Gurashi, K., Fower, A., Rodriguez-Romera, A., Reyat, J. S., Awad, S. A., Hargreaves, R., Kemble, S., et al. (2026) · Cell stem cell · doi:10.1016/j.stem.2026.01.010 · Cited by 27

Bone Marrow Adipose Tissue: Regulation of Osteoblastic Niche, Hematopoiesis and Hematological Malignancies

Labella, R., Vujačić, M., & Trivanović, D. I. (2023) · Stem Cell Reviews and Reports · doi:10.1007/s12015-023-10531-3 · Cited by 21

Turning the spotlight on bone marrow adipocytes in haematological malignancy and non‐malignant conditions

Austin, M. J., Kalampalika, F., Cawthorn, W. P., & Patel, B. G. (2023) · British Journal of Haematology · doi:10.1111/bjh.18748 · Cited by 23

Novel insights of EZH2-mediated epigenetic modifications in degenerative musculoskeletal diseases

Ma, Z., Chen, L., Wang, Y., Zhang, S., Zheng, J., Luo, Y., Wang, C., Zeng, H., Xue, L., Tan, Z. W., et al. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102034 · Cited by 19

Myeloma-bone marrow adipocyte axis in tumour survival and treatment response

Jafari, A., Fairfield, H. E., Andersen, T. L., & Reagan, M. R. (2021) · British Journal of Cancer · doi:10.1038/s41416-021-01371-4 · Cited by 19

PPARγ and C/EBPα enable adipocyte differentiation upon inhibition of histone methyltransferase PRC2 in malignant tumors

Zhao, J., Qian, H., An, Y., Chu, L., Tan, D., Qin, C., Sun, Q., Wang, Y., & Qi, W. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.107765 · Cited by 19

The Lipoprotein Transport System in the Pathogenesis of Multiple Myeloma: Advances and Challenges

Lazaris, V., Hatziri, A., Symeonidis, A. S., & Kypreos, K. E. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.638288 · Cited by 19

Adipocyte-Cancer Cell Interactions in the Bone Microenvironment

Otley, M. O. C., & Sinal, C. J. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.903925 · Cited by 18

Adipogenesis in Different Body Depots and Tumor Development

Trivanović, D. I., Vignjević, S., Djordjević, I. O., Кукољ, Т., Bugarski, D. S., & Jauković, A. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.571648 · Cited by 18

The role of bone marrow adipocytes in cancer progression: the impact of obesity

Hernandez, M., Shin, S., Muller, C., & Attané, C. (2022) · Cancer and Metastasis Reviews · doi:10.1007/s10555-022-10042-6 · Cited by 17

Targeting myeloma metabolism: How abnormal metabolism contributes to multiple myeloma progression and resistance to proteasome inhibitors

Zhou, X., He, R. Y., Hu, W., Luo, S., & Hu, J. (2024) · Neoplasia · doi:10.1016/j.neo.2024.100974 · Cited by 18

Emilin-2 is a component of bone marrow extracellular matrix regulating mesenchymal stem cell differentiation and hematopoietic progenitors

Ros, F. D., Persano, L., Bizzotto, D., Michieli, M., Braghetta, P., Mazzucato, M., & Bonaldo, P. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-021-02674-2 · Cited by 16

Role of bone marrow adipocytes in bone metastasis development and progression: a systematic review

Salamanna, F., Contartese, D., Errani, C., Sartori, M., Borsari, V., & Giavaresi, G. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1207416 · Cited by 15

Importance of circulating adipocytokines in multiple myeloma: a systematic review and meta-analysis based on case-control studies

Liu, R., Gao, D., Lv, Y., Zhai, M., & He, A. (2022) · BMC Endocrine Disorders · doi:10.1186/s12902-022-00939-2 · Cited by 16

Intermittent Exposure to a 16 Hz Extremely Low Frequency Pulsed Electromagnetic Field Promotes Osteogenesis In Vitro through Activating Piezo 1-Induced Ca2+ Influx in Osteoprogenitor Cells

Chen, Y., Braun, B. J., Menger, M. M., Ronniger, M., Falldorf, K., Histing, T., Nussler, A. K., & Ehnert, S. (2023) · Journal of Functional Biomaterials · doi:10.3390/jfb14030165 · Cited by 14

Bone Marrow Adipocytes Contribute to Tumor Microenvironment-Driven Chemoresistance via Sequestration of Doxorubicin

Kwak, J., & Lee, J. (2023) · Cancers · doi:10.3390/cancers15102737 · Cited by 14

RNA-seq reveals that anti-obesity irisin and triiodothyronine (T3) hormones differentially affect the purinergic signaling transcriptomics in differentiated human adipocytes

Mathias, L. S., Herman-de-Sousa, C., Cury, S. S., Nogueira, C. R., Correia‐de‐Sá, P., & de Oliveira, M. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2022.159276 · Cited by 14

Adipocytes and metabolism: Contributions to multiple myeloma

Fairfield, H. E., Karam, M., Schimelman, A., Qiang, Y., & Reagan, M. R. (2024) · Journal of bone oncology · doi:10.1016/j.jbo.2024.100609 · Cited by 13

Sclerostin-Neutralizing Antibody Treatment Rescues Negative Effects of Rosiglitazone on Mouse Bone Parameters

Farrell, M. L., Fairfield, H. E., Costa, S., D’Amico, A., Falank, C. R., Brooks, D. J., & Reagan, M. R. (2020) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.4170 · Cited by 11

Development and characterization of three cell culture systems to investigate the relationship between primary bone marrow adipocytes and myeloma cells

Fairfield, H. E., Condruti, R., Farrell, M. L., Iorio, R. D., Gartner, C. A., Vary, C., & Reagan, M. R. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2022.912834 · Cited by 11

Myeloma–Bone Interaction: A Vicious Cycle via TAK1–PIM2 Signaling

Harada, T., Hiasa, M., Teramachi, J., & Abe, M. (2021) · Cancers · doi:10.3390/cancers13174441 · Cited by 12

Macrophage heterogeneity in bone metastasis

Guo, J., Ma, R., & Qian, B. (2024) · Journal of bone oncology · doi:10.1016/j.jbo.2024.100598 · Cited by 11

EZH2 serves as a viable therapeutic target for myeloma-induced osteolytic bone destruction

Liu, R., Li, Z., Chen, R., Fang, Z., Liu, Z., & Liu, H. (2025) · Nature Communications · doi:10.1038/s41467-025-56506-5 · Cited by 10

Bone marrow adipocyte: Origin, biology and relationship with hematological malignancy

Wang, Y., Yang, C., Wan, J., Liu, P., Yu, H., Yang, X., & Ma, D. (2023) · International Journal of Laboratory Hematology · doi:10.1111/ijlh.14198 · Cited by 10

Bone marrow adipocytes provide early sign for progression from MGUS to multiple myeloma

El-Masri, B. M., Leka, B., Mustapha, F., Gundesen, M. T., Hinge, M., Lund, T., Andersen, T. L., Diaz‐delCastillo, M., & Jafari, A. (2024) · Oncotarget · doi:10.18632/oncotarget.28548 · Cited by 10

Che-1/miR-590-3p/TAZ axis sustains multiple myeloma disease

Bruno, T., Catena, V., Corleone, G., Cortile, C., Cappelletto, M. C., Bellei, B., Nicola, F. D., Amadio, B., Gumenyuk, S., Marchesi, F., et al. (2024) · Leukemia · doi:10.1038/s41375-024-02168-z · Cited by 10

Unraveling the Bone Tissue Microenvironment in Chronic Lymphocytic Leukemia

Giannoni, P., Marini, C., Cutrona, G., Sambuceti, G. M., Fais, F., & de Totero, D. (2023) · Cancers · doi:10.3390/cancers15205058 · Cited by 11

Lipid metabolism in multiple myeloma: pathogenesis, therapeutic opportunities, and future directions

Wang, H., Zhang, J., Ren, H., Chen, L., Ren, J., Liu, C., Wu, H., & Zhou, L. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1531928 · Cited by 10

Obesity, bone marrow adiposity, and leukemia: Time to act

Kumar, V., & Stewart, J. H. (2023) · Obesity Reviews · doi:10.1111/obr.13674 · Cited by 8

Bone marrow adipocytes in cancer: Mechanisms, models, and therapeutic implications

Bessot, A., Gunter, J. H., McGovern, J., & Bock, N. (2025) · Biomaterials · doi:10.1016/j.biomaterials.2025.123341 · Cited by 9

Bacterial infections exacerbate myeloma bone disease

Liu, R., Zhong, Y., Chen, R., Chen, S., Huang, Y., & Liu, H. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-021-03187-5 · Cited by 8

Interplay between fat cells and immune cells in bone: Impact on malignant progression and therapeutic response

Wilson, A., Garmo, L. C., & Podgorski, I. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108274 · Cited by 7

Molecular Crosstalk between Chromatin Remodeling and Tumor Microenvironment in Multiple Myeloma

Chakraborty, C., & Mukherjee, S. (2022) · Current Oncology · doi:10.3390/curroncol29120749 · Cited by 7

Engineering a Humanised Niche to Support Human Haematopoiesis in Mice: Novel Opportunities in Modelling Cancer

Sánchez‐Herrero, A., Calvo, I. A., Flandes‐Iparraguirre, M., Landgraf, M., Lahr, C. A., Shafiee, A., Granero‐Moltó, F., Sáez, B., Mazo, M. M., Paiva, B., et al. (2020) · Cancers · doi:10.3390/cancers12082205 · Cited by 7

Myeloma interaction with bone marrow stromal cells suppresses ciliogenesis and osteogenic potential in myeloma bone disease

Xie, Y., Liu, Z., Li, Q., Li, T., Guo, J. R., Hu, M., Jiantao, S., Jiang, H., Wang, J., Wang, S., et al. (2025) · Science Translational Medicine · doi:10.1126/scitranslmed.adq2961 · Cited by 6

Continued attention: The role of exosomal long non-coding RNAs in tumors over the past three years

Cao, J., Feng, B., Xv, Y., Yu, J., Cao, S., & Ma, C. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113666 · Cited by 6

Critical Assessment of In Vitro and In Vivo Models to Study Marrow Adipose Tissue

Reagan, M. R. (2020) · Current Osteoporosis Reports · doi:10.1007/s11914-020-00569-4 · Cited by 6

Incidence of hematologic malignancies and mortality associated with GLP-1 receptor agonist and SGLT2 inhibitor use in type 2 diabetes mellitus: results of a retrospective cohort study of electronic health records

Irons, E. E., Pfeil, K. A., Perez, J. A., & van Besien, K. (2026) · EClinicalMedicine · doi:10.1016/j.eclinm.2025.103749 · Cited by 6

Tackling myeloma bone disease: From pathophysiology to cutting-edge therapies

Roux, S., Debiais, F., & Vieillard, M.-H. (2025) · Blood Reviews · doi:10.1016/j.blre.2025.101305 · Cited by 7

Adipose Tissue-Derived Mediators in Multiple Myeloma: Linking Obesity to Bone Disease via Inflammatory Pathways

Stroe-Ionescu, A.-Ş., Tănase, A., Rotaru, I., Goanta, J. G., Pătraşcu, A. M., Boldeanu, M. V., Assani, M.-Z., Siloşi, I., Boldeanu, L., & Maria, D. T. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26125618 · Cited by 4

LAMP5 modulates IRF4 stability and nuclear transport: a critical mechanism in myeloma progression and therapy

Li, Z., Liu, R., Fang, Z., Chen, R., Yang, D., Li, Y., Liu, S., Wang, C., & Liu, H. (2025) · Oncogene · doi:10.1038/s41388-025-03513-x · Cited by 4

Bone marrow microenvironment: roles and therapeutic implications in obesity-associated cancer

Cheng, F., He, J., & Yang, J. (2023) · Trends in cancer · doi:10.1016/j.trecan.2023.03.007 · Cited by 4

Exosomal lncRNAs as diagnostic and therapeutic targets in multiple myeloma

Yan, H., Jiang, N., Li, X., Lin, C., Wang, F., Zhang, J., Chen, L., & Li, D. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2024.1522491 · Cited by 4

Exosomal RNAs and EZH2: unraveling the molecular dialogue driving tumor progression

Zwamel, A. H., Ahmad, A. T., Altalbawy, F. M. A., Malathi, H., Singh, A., Jabir, M. S., Aminov, Z., Lal, M., Kumar, A., & Jawad, S. F. (2025) · Medical Oncology · doi:10.1007/s12032-025-02648-x · Cited by 5

Screening and identification of cyprinid herpesvirus 2 (CyHV-2) ORF55-interacting proteins by phage display

Qian, M., Xiao, S., Yang, Y., Yu, F., Wen, J., Lu, L., & Wang, H. (2023) · Virology Journal · doi:10.1186/s12985-023-02026-x · Cited by 3

Promotion of Bone Lesions Through the Myeloma Integrin α6-Mediated Osteolytic Signaling

Liu, H., Wang, Z., He, J., Li, Z., Gao, J., Liu, R., Lin, P., & Yang, J. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.692190 · Cited by 3

Normalization of the Immunological Microenvironment and Sustained Minimal Residual Disease Negativity: Do We Need Both for Long-Term Control of Multiple Myeloma?

Bertuglia, G., Cani, L., Larocca, A., Gay, F., & D’Agostino, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232415879 · Cited by 3

comBO: A combined human bone and lympho-myeloid bone marrow organoid for pre-clinical modelling of haematopoietic disordersPreprint

Shen, Y., Benlabiod, C., Rodriguez-Romera, A., Watson, E., Reyat, J. S., Gurashi, K., Awad, S. A., Hargreaves, R., Kemble, S., Smith, C. G., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.02.16.638505 · Cited by 3

Metabolic reprogramming in tumor-associated cells of hematologic malignancies: mechanisms, crosstalk networks, and therapeutic implications in the tumor microenvironment

Hong, Z., Wu, Y., Liu, W., Li, D., & Xu, J. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1773233 · Cited by 2

Advances in the pathogenesis of multiple myeloma bone disease.

Hu, C., Kuang, C., & Zhou, W. (2023) · PubMed Central · doi:10.11817/j.issn.1672-7347.2023.220534 · Cited by 2

Molecular insights unlocking therapeutic potential for multiple myeloma and bone disease management

Bruno, T., Catena, V., Blandino, G., Fanciulli, M., & Agostino, S. D. (2024) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-024-03248-9 · Cited by 2

New role for adipocytes in tumour-associated bone disease

Morris, A. W. J. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0231-5 · Cited by 2

Bone Microenvironment

Jing, Y., & Chen, X. (2022) · Wiley eBooks · doi:10.1002/9783527837823.ch1 · Cited by 2

Donor fat‐to‐muscle ratio and kidney transplant outcomes: A proposition of metabolic memory

Kee, Y. K., Lee, J., Nam, B. Y., Joo, Y. S., Kang, S., Huh, K. H., & Park, J. T. (2024) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3781 · Cited by 1

m1A regulator‑mediated methylation modifications and gene signatures and their prognostic value in multiple myeloma

Fu, J., Han, X., Gao, W., Cui, J., Yu, M., & Cui, X. (2024) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2024.12768 · Cited by 1

Lifting the Veil on Myeloma Bone Disease

Chen, R., Liu, R., & Liu, H. (2025) · Health and Metabolism · doi:10.53941/hm.2025.100005 · Cited by 1

Effects of fatty acids and cholesterol on functions and behavior of bone marrow mesenchymal stem cells

Gonzalez-Garcia, B., Plaza, M., Fresco, M., Aparicio, C., Rocio, A., Muriana, F. J. G., & Jaramillo-Carmona, S. M. (2026) · iScience · doi:10.1016/j.isci.2026.114813 · Cited by 1

Adipocyte-derived β-hydroxybutyrate confers metabolic resilience in multiple myeloma

Li, Z., Song, C., Yang, P., Li, Y., Xia, T., Li, R., Li, W., Wang, Y., Jia, T., Liu, C., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-76595-0 · Cited by 1

Recent Advancements in Hematology: Knowledge, Methods and Dissemination, Part 2

Corre, J., Sabbah, M., Schjesvold, F. H., Zeidan, A. M., Buccisano, F., Sallman, D. A., Mazzucato, M., Madden, L. A., Martini, M., van Breda, E., et al. (2021) · Hemato · doi:10.3390/hemato2010004 · Cited by 1

Bone Marrow Adipose Tissue: Impacts on Bone Marrow Stem Cell Niche and Hematopoietic System

Trivanović, D. I., & Drvenica, I. T. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15717-2.00096-2 · Cited by 1

Editorial: Molecular Mechanisms of Multiple Myeloma

Gozzetti, A., Kok, C. H., & Li, C. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.870123 · Cited by 1

Recent Advancements in Hematology: Knowledge, Methods and Dissemination

Fitzgibbon, J., Busca, A., Gloghini, A., López‐Guillermo, A., Orazi, A., Carlo‐Stella, C., Andrès, E., van Breda, E., Busti, F., Garderet, L., et al. (2020) · Hemato · doi:10.3390/bloods1010003

Transforming growth factor-β and its signaling pathway in skeletal complications of malignancy

Juárez, P., Iduarte, B. I., & Fournier, P. G. J. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821666-8.00071-2

Biological relationship between bone and myeloma cells

Edwards, C. M., & Lawson, M. A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821666-8.00047-5

TGF-β and BMP Signaling Pathways in Cancer and Bone: In Sickness and in Health

Fournier, P. G. J., Fajardo-Yamamoto, L. M., & Juárez, P. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.11253-x

Roles of Iron in Chemoresistance of Multiple Myeloma Depends on the Interaction with Bone Marrow Stromal CellsPreprint

Jiang, H., Wang, S., Wang, J., Cheng, H., Li, X., Xie, Y., Wang, Y., Li, Q., Hu, M., Peng, Z., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-2274516/v1

Osteocyte-derived exosomes confer multiple myeloma resistance to chemotherapy through acquisition of cancer stem cell-like featuresPreprint

Cheng, F., Wang, Z., You, G., Liu, Y., He, J., & Yang, J. (2023) · Research Square · doi:10.21203/rs.3.rs-2535332/v1

Csontvelői zsírsejtek myeloma multiplexben

Kellermayer, Z. (2025) · Hematológia–Transzfuziológia · doi:10.1556/2068.2024.00204

Disruption of Marrow Microenvironments in Chronic Lymphocytic Leukemia by High-Resolution Synchrotron Micro-Computed TomographyPreprint

Lee, I. K., Obata, Y., Pomicter, A. D., Williams, J. A., Kikani, B., Jensen, C. E., Sborov, D. W., Stephens, D. M., & Acevedo, C. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.20.683519

New role for adipocytes in tumour-associated bone disease

Morris, A. W. J. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0231-5 · Cited by 2

EZH2 serves as a viable therapeutic target for myeloma-induced osteolytic bone destruction

Liu, R., Li, Z., Chen, R., Fang, Z., Liu, Z., & Liu, H. (2025) · Nature Communications · doi:10.1038/s41467-025-56506-5 · Cited by 10

Targeting Adipocytes for Treatment of Bone Lesions in Patients with Myeloma

Wolfgang, K. (2019) · Oncology Times · doi:10.1097/01.cot.0000581688.33761.10

Suppression of EZH2 Prevents the Shift of Osteoporotic MSC Fate to Adipocyte and Enhances Bone Formation During Osteoporosis

Jing, H., Liao, L., An, Y., Su, X., Liu, S., Shuai, Y., Zhang, X., & Jin, Y. J. (2015) · Molecular Therapy · doi:10.1038/mt.2015.152 · Cited by 165

Bone Marrow Adipocyte Promotes Epithelial-Mesenchymal-Transition-like Activation in Multiple Myeloma Via CXCL-12/CXCR4 Axis

Shu, L., Chen, S., Li, J., Wang, W., Liu, Y., Li, Y., Huang, H.-Y., Wu, X., & Liang, Y. (2021) · Blood · doi:10.1182/blood-2021-152400